Boris Quednow

Boris B. Quednow, Prof. Dr. rer. nat.

Coordinator Center for Psychatric Research
Group Leader

Phone: +41 (0)58 384 27 77

E-Mail

Curriculum vitae

Boris B. Quednow studied psychology and pharmacy at the University of Bonn. He wrote his dissertation on the neurobiological consequences of ecstasy (MDMA) use at the Ruhr-University of Bochum and worked as a research assistant at the Department of Psychiatry of the University of Bonn. At present, he is Associate Professor at the Department for Psychiatry, Psychotherapy and Psychosomatics at the Psychiatric Hospital of the University of Zurich. His main research interests are the behavioral neurotoxicology and neuroplasticity of illegal drug use, the neurochemistry of sensorimotor gating and higher cognitive functions, behavioral genetics, and disturbed information processing in psychiatric diseases, particularly in schizophrenia and drug addiction.

Complete Publication List

ORCID: https://orcid.org/0000-0001-7933-2865

Publications in ZORA:

ZORA Publication List

Download Options

Format for Download Link

Download asCSV Download asRIS Download asBIBTEX

Publications

Bavato, F., Seifritz, E., & Quednow, B. B. (2024). The multifaceted role of neurofilament light chain protein: emerging opportunities in primary psychiatric conditions Brain : A Journal of Neurology, 147, e5–e6. https://doi.org/10.1093/brain/awad281
Eggenberger, L., Janousch, C., Loher, M., Ribeaud, D., & Quednow, B. B. (2024). Substanzkonsum junger Menschen in der Schweiz: Verbreitung, Entwicklungen und Auswirkungen SuchtMagazin, 28–35.
Johnson-Ferguson, L., Shanahan, L., Bechtiger, L., Steinhoff, A., Zimmermann, J., Baumgartner, M. R., Binz, T. M., Eisner, M., Ribeaud, D., & Quednow, B. B. (2023). Associations of psychoactive substances and steroid hormones in hair: Findings relevant to stress research from a large cohort of young adults Psychoneuroendocrinology, 157, 106369. https://doi.org/10.1016/j.psyneuen.2023.106369
Kroll, S. L., Hulka, L. M., Kexel, A.-K., Vonmoos, M., Preller, K. H., Treyer, V., Ametamey, S. M., Baumgartner, M. R., Boost, C., Pahlisch, F., Rohleder, C., Leweke, F. M., & Quednow, B. B. (2023). Plasma endocannabinoids in cocaine dependence and their relation to cerebral metabotropic glutamate receptor 5 density Translational Psychiatry, 13, 325. https://doi.org/10.1038/s41398-023-02628-7
Coray, R. C., Zimmermann, J., Haugg, A., Baumgartner, M. R., Steuer, A. E., Seifritz, E., Stock, A., Beste, C., Cole, D. M., & Quednow, B. B. (2023). The functional connectome of 3,4‐methyldioxymethamphetamine‐related declarative memory impairments Human Brain Mapping, 44, 5079–5094. https://doi.org/10.1002/hbm.26438
Egger, K., Gudmundsen, F., Jessen, N. S., Baun, C., Poetzsch, S. N., Shalgunov, V., Herth, M. M., Quednow, B. B., Martin-Soelch, C., Dornbierer, D., Scheidegger, M., Cumming, P., & Palner, M. (2023). A pilot study of cerebral metabolism and serotonin 5-HT2A receptor occupancy in rats treated with the psychedelic tryptamine DMT in conjunction with the MAO inhibitor harmine Frontiers in Pharmacology, 14, 1140656. https://doi.org/10.3389/fphar.2023.1140656
Vock, F., Johnson-Ferguson, L., Bechtiger, L., Stulz, N., von Felten, J., Eisner, M., Hepp, U., Ribeaud, D., Shanahan, L., & Quednow, B. B. (2023). Substance use in sexual minority youth: prevalence in an urban cohort Child and Adolescent Psychiatry and Mental Health, 17, 109. https://doi.org/10.1186/s13034-023-00657-0
Sidorenko, N., Chung, H.-K., Grueschow, M., Quednow, B. B., Hayward-Könnecke, H., Jetter, A., & Tobler, P. N. (2023). Acetylcholine and noradrenaline enhance foraging optimality in humans Proceedings of the National Academy of Sciences of the United States of America, 120, 2305596120. https://doi.org/10.1073/pnas.2305596120
Coray, R. C., Berberat, J., Zimmermann, J., Seifritz, E., Stock, A.-K., Beste, C., Cole, D. M., Unschuld, P. G., & Quednow, B. B. (2023). Striatal Iron Deposition in Recreational MDMA (Ecstasy) Users Biological Psychiatry: Cognitive Neuroscience and Neuroimaging, 8, 956–966. https://doi.org/10.1016/j.bpsc.2023.02.005
Stock, A.-K., Werner, A., Kuntke, P., Petasch, M.-S., Bensmann, W., Zink, N., Koyun, A. H., Quednow, B. B., & Beste, C. (2023). Gamma-Aminobutyric Acid and Glutamate Concentrations in the Striatum and Anterior Cingulate Cortex Not Found to Be Associated with Cognitive Flexibility Brain Sciences, 13, 1192. https://doi.org/10.3390/brainsci13081192
Dornbierer, D. A., Zölch, N., Baur, D. M., Hock, A., Stucky, B., Quednow, B. B., Kraemer, T., Seifritz, E., Bosch, O. G., & Landolt, H. (2023). Nocturnal sodium oxybate increases the anterior cingulate cortex magnetic resonance glutamate signal upon awakening Journal of Sleep Research, 32, e13866. https://doi.org/10.1111/jsr.13866
Steinhoff, A., Shanahan, L., Bechtiger, L., Zimmermann, J., Ribeaud, D., Eisner, M., Baumgartner, M. R., & Quednow, B. B. (2023). When Substance Use Is Underreported: Comparing Self-Reports and Hair Toxicology in an Urban Cohort of Young Adults Journal of the American Academy of Child and Adolescent Psychiatry, 62, 791–804. https://doi.org/10.1016/j.jaac.2022.11.011
Bavato, F., Kexel, A.-K., Kluwe-Schiavon, B., Maceski, A., Baumgartner, M. R., Seifritz, E., Kuhle, J., & Quednow, B. B. (2023). A Longitudinal Investigation of Blood Neurofilament Light Chain Levels in Chronic Cocaine Users Molecular Neurobiology, 60, 3935–3944. https://doi.org/10.1007/s12035-023-03327-6
Zimmermann, J., Zölch, N., Coray, R., Bavato, F., Friedli, N., Baumgartner, M. R., Steuer, A. E., Opitz, A., Werner, A., Oeltzschner, G., Seifritz, E., Stock, A.-K., Beste, C., Cole, D. M., & Quednow, B. B. (2023). Chronic 3,4-Methylenedioxymethamphetamine (MDMA) Use Is Related to Glutamate and GABA Concentrations in the Striatum But Not the Anterior Cingulate Cortex International Journal of Neuropsychopharmacology, 26, 438–450. https://doi.org/10.1093/ijnp/pyad023
Bavato, F., Esposito, F., Dornbierer, D. A., Zölch, N., Quednow, B. B., Staempfli, P., Landolt, H.-P., Seifritz, E., & Bosch, O. G. (2023). Subacute changes in brain functional network connectivity after nocturnal sodium oxybate intake are associated with anterior cingulate GABA Cerebral Cortex, 33, 8046–8055. https://doi.org/10.1093/cercor/bhad097
Steuer, A. E., Bavato, F., Schnider, L. K., Dornbierer, D. A., Bosch, O. G., Quednow, B. B., Seifritz, E., Steuer, C., & Kraemer, T. (2023). Urinary concentrations of GHB and its novel amino acid and carnitine conjugates following controlled GHB administration to humans Scientific Reports, 13, 8983. https://doi.org/10.1038/s41598-023-36213-1
Bosch, O. G., Dornbierer, D. A., Bavato, F., Quednow, B. B., Landolt, H.-P., & Seifritz, E. (2023). Dexmedetomidine in Psychiatry: Repurposing of its Fast-Acting Anxiolytic, Analgesic and Sleep Modulating Properties Pharmacopsychiatry, 56, 44–50. https://doi.org/10.1055/a-1970-3453
Opitz, A., Petasch, M.-S., Klappauf, R., Kirschgens, J., Hinz, J., Dittmann, L., Dathe, A. S., Quednow, B. B., Beste, C., & Stock, A.-K. (2023). Does chronic use of amphetamine-type stimulants impair interference control? – A meta-analysis Neuroscience and Biobehavioral Reviews, 146, 105020. https://doi.org/10.1016/j.neubiorev.2022.105020
Huang, M.-C., Chen, C.-H., Liu, T.-H., Chung, A.-N., Liu, Y.-L., Quednow, B. B., & Bavato, F. (2023). Comorbidity of ketamine dependence with major depressive disorder increases the vulnerability to neuroaxonal pathology Journal of Psychiatric Research, 158, 360–364. https://doi.org/10.1016/j.jpsychires.2023.01.009
Butzke, I., Claussen, M. C., Quednow, B. B., & Iff, S. (2023). Anabolikakonsument in der Sprechstunde für Medikamente im Fitnesssport – Fallvorstellung Suchtmedizin - Addiction Medicine, 25, 19–24. https://www.ecomed-medizin.de/anabolikakonsument-in-der-sprechstunde-fuer-medikamente-im-fitnesssport-fallvorstellung

Quicklinks

Main navigation